Literature DB >> 16005556

Impulsivity as a common process across borderline personality and substance use disorders.

Marina A Bornovalova1, C W Lejuez, Stacey B Daughters, M Zachary Rosenthal, Thomas R Lynch.   

Abstract

Borderline personality disorder (BPD) is a significant public health problem characterized by persistent problems with emotional, behavioral, cognitive, and interpersonal functioning. Research indicates an especially high rate of comorbidity between BPD and Substance Use Disorders (SUD). In trying to better understand, and therefore improve the assessment, prevention, and treatment of these disorders, researchers have considered the role of impulsivity. Indeed, impulsivity consistently has been shown to be a biologically-based, heritable characteristic with emergent psychological properties linked to the development and maintenance of BPD and SUD. Following from a previous review of the comorbidity between BPD and SUD (Trull, T. J., Sher, K. J., Minks-Brown, C., Durbin, J., & Burr, R. (2000). Borderline personality disorder and substance use disorders: A review and integration. Clinical Psychology Review, 20, 235-253), the current manuscript revisits the role of impulsivity as a common process across these disorders with a specific focus on the multidimensional nature of impulsivity and its interaction with trait and state negative affectivity.

Entities:  

Mesh:

Year:  2005        PMID: 16005556     DOI: 10.1016/j.cpr.2005.05.005

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  56 in total

1.  Risk factors in the relationship between gender and crack/cocaine.

Authors:  C W Lejuez; Marina A Bornovalova; Elizabeth K Reynolds; Stacey B Daughters; John J Curtin
Journal:  Exp Clin Psychopharmacol       Date:  2007-04       Impact factor: 3.157

2.  Sensation seeking and risk-taking propensity as mediators in the relationship between childhood abuse and HIV-related risk behavior.

Authors:  Marina A Bornovalova; Marya A Gwadz; Christopher Kahler; W M Aklin; C W Lejuez
Journal:  Child Abuse Negl       Date:  2007-12-21

3.  Neural correlates of speeded as compared with delayed responses in a stop signal task: an indirect analog of risk taking and association with an anxiety trait.

Authors:  Chiang-shan Ray Li; Herta H-A Chao; Tien-Wen Lee
Journal:  Cereb Cortex       Date:  2008-08-04       Impact factor: 5.357

4.  Distinguishing general and specific personality disorder features and implications for substance dependence comorbidity.

Authors:  Seungmin Jahng; Timothy J Trull; Phillip K Wood; Sarah L Tragesser; Rachel Tomko; Julia D Grant; Kathleen K Bucholz; Kenneth J Sher
Journal:  J Abnorm Psychol       Date:  2011-08

5.  Examining Risk for Frequent Cocaine Use: Focus on an African American Treatment Population.

Authors:  Tamika Chere Barkley Zapolski; Patrick Baldwin; Carl W Lejuez
Journal:  Subst Use Misuse       Date:  2016-04-21       Impact factor: 2.164

6.  Recent Insights into the Neurobiology of Impulsivity.

Authors:  Marci R Mitchell; Marc N Potenza
Journal:  Curr Addict Rep       Date:  2014-12-01

Review 7.  Impulsivity and Cluster B Personality Disorders.

Authors:  Daniel Turner; Alexandra Sebastian; Oliver Tüscher
Journal:  Curr Psychiatry Rep       Date:  2017-03       Impact factor: 5.285

8.  The Roles of Emotion Regulation Difficulties and Impulsivity in the Associations between Borderline Personality Disorder Symptoms and Frequency of Nonprescription Sedative Use and Prescription Sedative/Opioid Misuse.

Authors:  Julia R Richmond; Matthew T Tull; Kim L Gratz
Journal:  J Contextual Behav Sci       Date:  2020-03-16

9.  Addictions and Personality Traits: Impulsivity and Related Constructs.

Authors:  Marci R Mitchell; Marc N Potenza
Journal:  Curr Behav Neurosci Rep       Date:  2014-03-01

Review 10.  Impulsivity in borderline personality disorder: a matter of disturbed impulse control or a facet of emotional dysregulation?

Authors:  Alexandra Sebastian; Gitta Jacob; Klaus Lieb; Oliver Tüscher
Journal:  Curr Psychiatry Rep       Date:  2013-02       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.